Femasys (FEMY) Notes Payables (2020 - 2025)

Femasys' (FEMY) quarterly Notes Payables came in at $276489.0 in Q3 2025, down 95.45% on a QoQ basis from $6.1 million in Q2 2025.

Femasys (FEMY) Notes Payables (2020 - 2025) Analysis & Trends

Femasys (FEMY) has 6 years of Notes Payables data on file, last reported at $276489.0 in Q3 2025.

Quarterly Notes Payables changed N/A year-over-year to $276489.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $276489.0 (changed N/A YoY) and the FY2024 annual result came in at $5.4 million, changed N/A from the prior year.
Notes Payables eased to $276489.0 in Q3 2025, from $6.1 million in the prior quarter.
In the past five years, Notes Payables ranged from a high of $6.1 million in Q2 2025 to a low of $45666.0 in Q1 2022.
A 5-year average of $1.6 million and a median of $302100.0 in 2021 frame the typical range for Notes Payables.
Annual changes were most pronounced in 2021 — Notes Payables plunged 71.25% — and 2023, when it advanced 0.98%.
Tracing FEMY's Notes Payables over 5 years: stood at $181123.0 in 2021, then retreated by 21.99% to $141298.0 in 2022, then soared by 100.52% to $283334.0 in 2023, then jumped by 1808.08% to $5.4 million in 2024, then slumped by 94.89% to $276489.0 in 2025.
The last three Notes Payables figures came in at $276489.0 (Q3 2025), $6.1 million (Q2 2025), and $5.8 million (Q1 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Intuitive Surgical	132.71 Bn	127.50 Bn	1.96 Bn
2	Becton Dickinson	51.57 Bn	50.71 Bn	2.32 Bn
3	Alcon	35.52 Bn	34.17 Bn	1.68 Bn
4	Resmed	33.28 Bn	31.81 Bn	861.22 Mn
5	Medline	27.86 Bn	25.18 Bn	2.22 Bn
6	West Pharmaceutical Services	25.15 Bn	24.71 Bn	329.20 Mn
7	Solventum	15.31 Bn	14.91 Bn	1.29 Bn
8	Cooper Companies	14.86 Bn	14.72 Bn	735.40 Mn
9	Baxter International	13.63 Bn	11.48 Bn	1.03 Bn
10	Femasys	8.98 Mn	7.54 Mn	189,391.00

Download Data